Metabolic Effects of Melatonin Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03859934

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:31.995872+00:00

Published At

2021-08-25T00:00:00+00:00

Record Updated At

2021-08-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metabolic Disease", "Insulin Sensitivity", "Glucose Metabolism Disorders (Including Diabetes Mellitus)", "Type 2 Diabetes Mellitus", "Blood Pressure", "Inflammation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-08-25"

protocolSection.identificationModule.nctId

"NCT03859934"

protocolSection.identificationModule.officialTitle

"Metabolic Effects of Melatonin Treatment"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Metabolic Disease (protocolSection.conditionsModule.conditions)
• Insulin Sensitivity (protocolSection.conditionsModule.conditions)
• Glucose Metabolism Disorders (Including Diabetes Mellitus) (protocolSection.conditionsModule.conditions)
• Type 2 Diabetes Mellitus (protocolSection.conditionsModule.conditions)
• Blood Pressure (protocolSection.conditionsModule.conditions)
• Inflammation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.